XenMatrix AB surgical graft is the first antibacterial coated, non-crosslinked porcine dermal graft to inhibit the colonization of MSRA, E.coli and other bacteria in preclinical model. It uses a combination of well characterized antibiotics, ripampin and minocyclin, to offer an unmatched level of graft protection in challenging vernal hernia repair. In vitro testing demonstrated a significant zone of inhibition against the most common bacteria associated with hernia related complication.
